Type 2 Diabetes: Glycemic Control in the COVID-19 Era

Add to Calendar Type 2 Diabetes: Glycemic Control in the COVID-19 Era 6/14/2022 9:00:00 AM 6/14/2022 10:35:00 AM America/New_York false MM/DD/YYYY


Date & Location
Tuesday, June 14, 2022, 9:00 AM - 10:35 AM

Overview
The intent of this activity is to provide an overview of the impact of the COVID-19 pandemic lockdown and infection on glycemic control in patients with Type 2 Diabetes.  The goals of this activity are to illustrate the effects of both the lockdown and COVID-19 infection on the management of glycemic control and to propose potential options to assist in achieving glycemic control moving forward.

Target Audience
Specialties - General Pharmacy
Professions - Fellow, Pharmacist


Objectives
  Upon completion of this activity, participants should be better able to:

 


  1. Recall the pathophysiology and general diagnostic criteria for type 2 diabetes (T2DM).
  2. Identify the effects of the pandemic lockdown and COVID-19 infection on management of glycemic control in patients with T2DM.
  3. Describe glycemic management interventions and technologies that have emerged during COVID-19 pandemic to support long-term glycemic control.

Registration

Registration Will Open On or Before Wednesday, May 11th.   This activity for EMSOP Fellows and their AstraZeneca Host colleagues.

Program in process of being developed.  

Thank you for your patience.


Accreditation and Credit Designation

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credits
Non-Physician Attendance (1.00 hours), ACPE Credits (1.00 hours)